SCT800

BIOLOGICAL3 trials

Sponsors

Sinocelltech Ltd., Institute of Hematology & Blood Diseases Hospital, China

Conditions

Hemophilia AHemophilia A With Inhibitor

Phase 1

Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

Sinocelltech Ltd.Hemophilia A

Start: 2016-09-30End: 2017-07-31Target: 16Updated: 2016-09-02

Phase 3

Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A

Sinocelltech Ltd.Hemophilia A

Start: 2016-10-31End: 2018-06-30Target: 50Updated: 2016-10-03

Phase 4

ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor

RecruitingNCT05888870

Institute of Hematology & Blood Diseases Hospital, ChinaHemophilia A With Inhibitor

Start: 2023-11-22End: 2026-12-01Target: 50Updated: 2025-02-24